A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11.7 | $240.6 | 7% |
|
| Shares Out (Mil) | 2,664.8 | 54.0 | 98% |
|
| Institutional Ownership | 91.8% | 93.1% | 60% |
|
| Float (Mil) | 2,829.9 | 41.4 | 97% |
|
| Beta | 0.70 | 0.95 | 41% |
|
| Avg Daily Volume (000s) | 16 | 604 | 19% |
|
| Price Change (52-week) |
(47.8%) | 49.2% | 20% |
|
| Growth | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 12.5% | na |
|
| Net Income (5yr) | 47.5% | (10.1%) | 93% |
|
| EPS (5yr) | 14.9% | 15.8% | 56 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.9%) | (15.7%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | 1 | 1 | |
| Current EPS | $0.000 | ($3.140) | ($2.520) | |
| Month Ago EPS | na | ($3.140) | ($2.520) | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | ($0.300) | ($0.930) | ($0.640) | |
| Year/Year Chg | (100.0%) | na | na | |
| Financials | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1 | $37 | 2% |
|
| Net Income (TTM) (Mil) | ($7) | ($44) | 32% |
|
| EPS (TTM) | ($0.003) | ($1.600) | 39% |
|
| Operating Cash Flow (TTM) (Mil) | ($11) | ($34) | 20% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | $2 | 37% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $4 | 22% |
|
| Enterprise Value (Q1) (Mil) | $10 | $175 | 7% |
|
| Valuation | BLRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 220.50 | 2.30 | 100% |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BLRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 80.0% | 67.3% | 89% |
|
| Net Margin | (502.1%) | (74.8%) | 2% |
|
| ROA | (18.2%) | (47.6%) | 21% |
|
| ROE | (41.3%) | (54.9%) | 17% |
|
| Liabilities to Assets | 50.4% | 29.3% | 43% |
|
| F-Score | 2 | 3 | 7% |
|
BioLineRx Ltd. did not pass any screens on 10/7/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
